MAPT and Alzheimer disease: Specifically, disruption in glucose metabolism associated with early mitochondrial dysfunction was detected in multiple animal models and AD patients not only may be a direct determinant of oxidative stress and synaptic dysfunction, but that they contribute to early disease mechanisms before any evidence of Aβ or tau pathology (Trushina et al., 2012).